FAM171A2 and cancer: Although direct experimental evidence for FAM171A2 is currently limited, transcriptomic profiling from large-scale cancer datasets (e.g., TCGA) indicates differential expression patterns across multiple tumor types, further supporting its potential role in cancer pathogenesis [10,12].